Our Year in Review: Insights, outcomes, and highlights that shaped 2025. Read the full report!
Aligning Science Across Parkinson's Logo Text

Combining biomarkers for prognostic modelling of Parkinson’s disease

Output Details

Preprint November 2, 2021

Published July 12, 2022

Patients with Parkinson’s disease (PD) have variable rates of progression. More accurate prediction of progression could improve selection for clinical trials. Although some variance in clinical progression can be predicted by age at onset and phenotype, we hypothesise that this can be further improved by blood biomarkers. We evaluated the relationship between serum NfL and baseline and longitudinal clinical measures as well as patients’ genetic (GBA and APOE) status.
Tags
  • APOE (Apolipoprotein E)
  • Biomarkers
  • Blood
  • DNA
  • GBA (Glucocerebrosidase)
  • Genotyping
  • Motor symptoms
  • NfL (Neurofilament light)
  • Original Research
  • Prognostic modeling
  • SNPs (Single Nucleotide Polymorphisms)

Meet the Authors

  • User avatar fallback logo

    Raquel Real, PhD

    Key Personnel: Team Hardy

    University College London

  • Ed Jabbari

    Key Personnel: Team Hardy

    University College London

  • Roger Barker, PhD

    Co-PI (Core Leadership): Team Jakobsson

    University of Cambridge

  • Nicholas Wood, PhD

    Lead PI (Core Leadership): Team Wood

    University College London

  • John Hardy, PhD

    Lead PI (Core Leadership): Team Hardy

    University College London

  • Huw Morris

    Collaborating PI: Team Hardy

    University College London

  • User avatar fallback logo

    Christine Girges

    External Collaborator

  • User avatar fallback logo

    Viorica Chelban

    External Collaborator

  • User avatar fallback logo

    Katherine A Grosset

    External Collaborator

  • User avatar fallback logo

    John Woodside

    External Collaborator

  • User avatar fallback logo

    Manuela Tan

    External Collaborator

  • User avatar fallback logo

    Tong Guo

    External Collaborator

  • User avatar fallback logo

    Michael Lawton

    External Collaborator

  • User avatar fallback logo

    Amanda Heslegrave

    External Collaborator

  • User avatar fallback logo

    Nirosen Vijiaratnam

    External Collaborator

  • User avatar fallback logo

    Ben-Shlomo Yoav

    External Collaborator

  • User avatar fallback logo

    Thomas Foltynie

    External Collaborator

  • User avatar fallback logo

    Henry Houlden

    External Collaborator

  • User avatar fallback logo

    Henrik Zetterberg

    External Collaborator

  • User avatar fallback logo

    Dilan Athauda

    External Collaborator

  • User avatar fallback logo

    Nigel Williams

    External Collaborator

  • User avatar fallback logo

    Donald Grosset

    External Collaborator

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.